Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 6Carcinoma, Basal Cell 4Bowen's Disease 2Warts 1Uterine Cervical Dysplasia 1Keratosis 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

resiquimod 6VP-102 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cantharidin 22-Propanol 2methyl 5-aminolevulinate 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1Sugars 1Photochemotherapy 1Nitric Oxide 1Maltose 1Interferon-alpha 1Imiquimod 1Exercise 1Equipment and Supplies 1Cryotherapy 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Warts × methyl 5-aminolevulinate × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡